Invest now
Ambalal Sarabhai Enterprises share price
High risk
You have to be logged in to add this to Watchlist.- ₹42.00(-0.99%)September 8, 2026 15:29:24 PM IST
- NSE
- BSE
- Vol : 2.99 K (NSE + BSE)Last 20 day avg : 40.57 K
Ambalal Sarabhai Enterprises is trading -0.99% lower at Rs 42.00 as compared to its last closing price. Ambalal Sarabhai Enterprises has been trading in the price range of 42.96 & 42.00. Ambalal Sarabhai Enterprises has TTM P/E ratio 18.47 as compared to the sector P/E of 37.01.The company posted a net profit of 3.98 Crores in its last quarter.Listed peers of Ambalal Sarabhai Enterprises include Aurobindo Pharma (1.69%), Neuland Laboratories (4.82%), Pfizer (-6.11%).The Mutual Fund holding in Ambalal Sarabhai Enterprises was at -% in . The MF holding has - from the last quarter. The FII holding in Ambalal Sarabhai Enterprises was at 0.34% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 08 Sep 2026, 10:07 PM IST
- Debt To EquityHigher than industry0.40The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates Fair Valuation1.55The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Ambalal Sarabhai Enterprises Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | 1,686.00 | 1.69 | 97,008.71 | 25.09 | 2.35 | 0.26 | 2.89 |
| Neuland Laboratories | 23,973.70 | 4.82 | 30,647.24 | 64.28 | 12.62 | 0.18 | 13.90 |
| Pfizer | 4,313.45 | -6.11 | 19,753.69 | 27.53 | 4.97 | 1.64 | 0.86 |
| Unichem Laboratories | 555.00 | -2.54 | 3,924.41 | 54.27 | 1.53 | - | 2.40 |
| Jagsonpal Pharmaceuticals | 237.00 | -0.36 | 1,549.19 | 34.27 | 5.43 | 1.12 | 2.39 |
Ambalal Sarabhai Enterprises Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-21 | Audited Results & A.G.M. |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
About the company Ambalal Sarabhai Enterprises
- IndustryMajor Drugs
- ISININE432A01017
- BSE Code500009
- NSE Code
Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparations (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in the oncology, infertility and Uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Pvt. Ltd., is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited, is a manufacturer of analytical and test and measuring instruments, distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.
Ambalal Sarabhai Enterprises Share Price FAQs
Ambalal Sarabhai Enterprises is trading at 42.00 as on Tue Sep 08 2026 09:59:24. This is -0.99% lower as compared to its previous closing price of 42.42.
The market capitalization of Ambalal Sarabhai Enterprises is 321.86 Cr as on Tue Sep 08 2026 09:59:24.
The 52 wk high for Ambalal Sarabhai Enterprises is 49.98 whereas the 52 wk low is 23.12
Ambalal Sarabhai Enterprises can be analyzed on the following key metrics -
- TTM P/E: 18.47
- Sector P/E: 37.01
- Dividend Yield: 0.00%
- D/E ratio: -
Ambalal Sarabhai Enterprises reported a net profit of 17.80 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Ambalal Sarabhai Enterprises QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.